Advertisement

The Scientist

» cancer, cell & molecular biology and culture

Most Recent

image: Science Gone Social

Science Gone Social

By , , , , and | October 1, 2014

Scientists are beginning to embrace social media as a viable means of communicating with public audiences.

0 Comments

image: Sleep Tight

Sleep Tight

By | October 1, 2014

Bed bugs are but one example of a species whose populations have evolved in response to human behavior.

0 Comments

image: Setting the Record Straight

Setting the Record Straight

By | October 1, 2014

Scientists are taking to social media to challenge weak research, share replication attempts in real time, and counteract hype. Will this online discourse enrich the scientific process?

3 Comments

image: Recruiting Anthrax to Oncology

Recruiting Anthrax to Oncology

By | September 26, 2014

In the latest development in trying to use Bacillus anthracis to kill cancer, researchers send “antibody mimics” inside tumor cells.

0 Comments

image: Thomson Reuters Predicts Nobelists

Thomson Reuters Predicts Nobelists

By | September 25, 2014

Using citation statistics, the firm forecasts which researchers are likely to take home science’s top honors this year.

2 Comments

image: Heritable Histones

Heritable Histones

By | September 18, 2014

Scientists show how roundworm daughter cells remember the histone modification patterns of their parents.

3 Comments

image: Giant DNA Origami

Giant DNA Origami

By | September 18, 2014

Researchers create the largest 3-D DNA structures to date, many times bigger than previously constructed origami shapes.

0 Comments

image: Small Wonders

Small Wonders

By | September 11, 2014

Sangeeta Bhatia, creator of miniature medical technologies, has won the Lemelson-MIT Prize.

0 Comments

image: Watson to Match Patients to Clinical Trials

Watson to Match Patients to Clinical Trials

By | September 8, 2014

IBM’s cognitive computer will be individualizing trial plans for cancer patients at the Mayo Clinic.

0 Comments

image: FDA Gives Nod to Melanoma Drug

FDA Gives Nod to Melanoma Drug

By | September 8, 2014

The US Food and Drug Administration last week approved the first of a new type of immunotherapy that aims to pit a patient’s own immune system against her cancer.

2 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
Life Technologies